7Baggers
Quarterly
Annual
    Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                        
      cash flows from operating activities
    		                        
      net income
    		-21,000 6,899,000 -19,112,000 6,574,000 3,928,000 -7,342,000 -9,248,000 665,000 -16,252,000 -21,443,000 -22,668,000 -15,166,000 -17,250,000 -25,148,000 -22,503,000 -11,348,000 -9,168,000 -19,783,000 -14,616,000 -22,751,000 -25,006,000 -19,061,000 -13,117,000 -9,665,000 
      adjustments to reconcile net income to net cash from operating activities
    		                        
      depreciation and amortization
    		3,215,000 2,901,000 3,182,000 3,192,000 3,254,000 3,228,000 2,813,000 2,880,000 2,921,000 2,891,000 3,029,000 2,643,000 2,690,000 2,660,000 1,133,000 488,000 447,000 426,000 380,000 311,000 310,000 294,000 276,000 283,000 
      stock-based compensation
    		8,231,000 8,611,000 9,551,000 11,148,000 11,470,000 11,204,000 10,714,000 8,757,000 8,218,000 7,905,000 7,138,000 6,844,000 6,690,000 6,327,000 5,303,000 3,582,000 3,775,000 3,816,000 3,922,000 2,921,000 2,782,000 1,875,000 1,142,000 247,000 
      acquired in-process research & development
    		                        
      benefit from allowance of credit losses
    		87,000 32,000 637,000                      
      change in fair value of contingent consideration
    		   0 0 600,000 1,800,000 2,100,000 8,100,000                
      deferred income taxes
    		-1,752,000 7,854,000 -2,060,000                      
      other items
    		121,000 2,759,000 1,136,000            -577,000 23,000 61,000        
      changes in operating assets and liabilities
    		                        
      accounts receivable
    		-5,353,000 -6,721,000 6,058,000 -8,267,000 -1,608,000 -7,226,000 4,670,000 -7,748,000 -960,000 -8,855,000 1,595,000 -2,329,000 -1,083,000 -4,106,000 -1,480,000 -620,000 -3,411,000 6,655,000 -13,405,000 -7,000,000 332,000 -482,000 -377,000 -208,000 
      inventory
    		-8,202,000 -14,999,000 -14,419,000 -6,427,000 -4,846,000 -4,360,000 -10,120,000 2,167,000 36,000 3,205,000 3,015,000 5,563,000 -125,000 647,000 -7,193,000 -18,753,000 -14,173,000 -10,856,000 -3,571,000 -2,956,000 -4,728,000 -2,911,000 -1,391,000 -1,648,000 
      prepaid expenses and other current assets
    		-2,603,000 802,000 2,467,000 -8,589,000 -1,805,000 -859,000 850,000 -2,698,000 322,000 40,000 1,474,000 -2,015,000 570,000 -355,000 860,000 -2,215,000 377,000 752,000 223,000 -1,843,000 200,000 -47,000 938,000 -2,098,000 
      other assets
    		-167,000 -292,000 -319,000 -307,000 -458,000 -1,734,000 -134,000 -305,000 81,000 42,000 -25,000 48,000 8,000 -181,000 -100,000 -106,000 -100,000 -112,000 228,000 28,000 -322,000 1,000 -6,000 185,000 
      accounts payable
    		675,000 3,574,000 -2,685,000 3,437,000 2,609,000 -2,625,000 5,593,000 -1,049,000 364,000 -376,000 2,529,000 -2,924,000 1,148,000 -2,000,000 914,000 1,245,000 -1,313,000 3,288,000 1,558,000 1,650,000 1,677,000 453,000 -1,334,000 1,453,000 
      accrued liabilities
    		-5,365,000 -3,692,000 4,228,000 4,510,000 345,000 -1,086,000 118,000 -708,000 158,000 682,000 900,000 -998,000 122,000 469,000 -1,569,000 685,000 1,934,000 638,000 936,000 -1,466,000 674,000 1,266,000 681,000 -83,000 
      accrued compensation and benefits
    		11,197,000 8,384,000 1,350,000 2,058,000 443,000 3,718,000 -6,663,000 3,736,000 841,000 3,460,000 -4,925,000 3,108,000 2,113,000 1,849,000 -915,000 -1,568,000 2,227,000 1,786,000 128,000      
      operating lease liabilities
    		859,000 866,000 750,000                      
      other liabilities
    		    0                    
      net cash from operating activities
    		922,000 16,978,000 -9,236,000 5,630,000 12,344,000 -19,209,000 -781,000 9,353,000 3,847,000 -842,000 -9,167,000 -6,776,000 -2,994,000 -11,953,000 -25,583,000 -28,314,000 -19,146,000 -12,975,000 -23,307,000 -28,136,000 -23,904,000 -18,359,000 -13,055,000 -9,296,000 
      capex
    		-3,317,000 -1,238,000 -3,059,000 -1,307,000 -1,193,000 -256,000 -794,000 -335,000 -963,000 -634,000 -291,000 -1,084,000 -684,000 -370,000 -123,000 -1,023,000 -648,000 -553,000 -714,000 -377,000 -233,000 -379,000 -350,000 -222,000 
      free cash flows
    		-2,395,000 15,740,000 -12,295,000 4,323,000 11,151,000 -19,465,000 -1,575,000 9,018,000 2,884,000 -1,476,000 -9,458,000 -7,860,000 -3,678,000 -12,323,000 -25,706,000 -29,337,000 -19,794,000 -13,528,000 -24,021,000 -28,513,000 -24,137,000 -18,738,000 -13,405,000 -9,518,000 
      cash flows from investing activities
    		                        
      purchases of property and equipment
    		-3,317,000 -1,238,000 -3,059,000 -1,307,000 -1,193,000 -256,000 -794,000 -335,000 -963,000 -634,000 -291,000 -1,084,000 -684,000 -370,000 -123,000 -1,023,000 -648,000 -553,000 -714,000 -377,000 -233,000 -379,000 -350,000 -222,000 
      purchases of short-term investments
    		-69,103,000 -143,399,000 -27,742,000 -137,690,000 -114,298,000 -122,307,000 -52,309,000 -46,674,000 -118,438,000           -1,194,000 -1,979,000 -22,933,000 -10,298,000 -55,093,000 
      proceeds from sales and maturities of short-term investments
    		142,549,000 67,464,000 169,033,000 101,075,000 104,438,000 53,940,000 53,797,000 36,979,000        0 0 0 12,592,000 13,913,000 19,668,000 34,752,000 14,697,000  
      net cash from investing activities
    		70,129,000 -77,173,000 138,232,000 -37,922,000 -11,053,000 -68,623,000 694,000 -10,030,000 -99,401,000 -10,632,000 -291,000 -1,084,000 -684,000 -370,000 -140,864,000 -1,023,000 -648,000 -553,000 11,878,000 12,342,000 17,456,000 11,440,000 4,049,000 -48,115,000 
      cash flows from financing activities
    		                        
      payment of contingent consideration recognized at acquisition
    		    0                    
      proceeds from exercise of stock options
    		2,525,000 241,000 248,000 578,000 878,000 864,000 1,930,000 161,000 3,577,000 480,000 1,444,000 318,000 1,523,000 2,095,000 2,821,000 1,055,000 1,296,000 1,008,000 344,000 43,000 111,000 308,000 44,000 3,000 
      net cash from financing activities
    		2,525,000 241,000 248,000 578,000 878,000 -6,766,000 1,930,000 161,000 131,883,000 480,000 1,444,000 202,000 1,523,000 112,573,000 56,215,000 1,055,000 1,296,000 141,495,000 344,000 110,492,000 111,000 308,000 44,000 135,579,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		710,000 -1,269,000 1,702,000                      
      net increase in cash, cash equivalents, and restricted cash
    		74,286,000 -61,223,000 130,946,000                      
      cash, cash equivalents and restricted cash, beginning of year
    		0 0 117,525,000                      
      cash, cash equivalents and restricted cash, end of period
    		74,286,000 -61,223,000 248,471,000                      
      supplemental disclosure of cash flow information
    		                        
      cash paid for interest
    		   14,000 16,000   0 0 0 1,000 0 1,000 2,007,000 170,000 253,000 256,000 264,000 329,000 339,000 367,000 370,000 360,000 358,000 
      cash paid for taxes
    		78,000 367,000 403,000 161,000 0   23,000 5,000   0 0       0 0   0 
      noncash investing and financing activities
    		                        
      property and equipment acquired but not yet paid
    		 -23,000 30,000 196,000 -34,000 25,000 16,000 38,000                 
      property and equipment acquired from tenant improvement allowance
    		0 784,000 4,116,000                      
      common stock issuance for acquired in-process research & development
    		   0                     
      loss on disposal of property and equipment
    		                        
      acquired in-process research and development
    		                        
      amortization of debt issuance costs
    		           0 0 4,424,000 567,000 180,000 180,000 179,000 235,000 214,000 225,000 269,000 165,000  
      (reversal of) benefit from allowance of credit losses
    		                        
      changes in operating assets and liabilities, net of business acquisition
    		                        
      payment of contingent consideration
    		                        
      acquisition of a business, net of cash acquired
    		           0 0 0 -140,741,000          
      payment of debt issuance costs
    		           0 0 0 -106,000         0 
      proceeds from debt
    		           0 0 0 75,000,000         10,000,000 
      repayment of debt
    		           -116,000 0 -79,500,000 -21,500,000          
      proceeds from offering of common stock upon follow-on public offering
    		       0                 
      payment of common stock offering costs upon follow-on public offering
    		       0                 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		                        
      net increase in cash, cash equivalents and restricted cash
    		                        
      cash and cash equivalents, beginning of year
    		   0 0 0 238,846,000 0 0 0 220,878,000 0 0 0 241,181,000 0 0 0 171,082,000 0 0 0 98,306,000 0 
      cash, cash equivalents and restricted cash, end of year
    		                        
      common stock issuance for business acquisition
    		           0 0 0 55,728,000          
      contingent consideration for business acquisition
    		           0 0 880,000 6,750,000          
      common stock issuance for exclusive license asset
    		           0 0 0 3,637,000          
      accrued loan fees as debt issuance costs
    		           0 0 0 4,500,000         750,000 
      benefit from (reversal of) allowance of credit losses
    		    13,000 45,000 1,000                  
      deferred income taxes and other items
    		    -988,000 -516,000 -1,184,000 1,446,000 8,000 -428,000 -1,210,000 -4,379,000 2,089,000            
      lease liabilities
    		                        
      effect of exchange rate changes on cash and cash equivalents
    		    -189,000 -164,000 -584,000 -1,969,000 1,766,000 1,050,000 316,000 -261,000 -188,000 -72,000 13,000 183,000 99,000 -108,000 -177,000 153,000 -112,000 -43,000 -10,000 -10,000 
      net increase in cash and cash equivalents
    		      1,259,000 -2,485,000    -7,919,000 -2,343,000   -28,099,000 -18,399,000     -6,654,000 -8,972,000 78,158,000 
      cash and cash equivalents, end of period
    		    1,980,000 -94,762,000 240,105,000  38,095,000 -9,944,000 213,180,000  -2,343,000 100,178,000 130,962,000  -18,399,000 127,859,000 159,820,000  -6,449,000 -6,654,000 89,334,000  
      lease liability
    		     -333,000 9,000 18,000 17,000 16,000 20,000 28,000 34,000 39,000 42,000 52,000 142,000 155,000 161,000 -30,000 -48,000 -16,000 -32,000 -32,000 
      net decrease in cash and cash equivalents
    		         -9,944,000 -7,698,000    -110,219,000    -11,262,000      
      common stock issuance for acquired in-process research and development
    		                        
      cash and cash equivalents, end of year
    		                        
      reversal of allowance of credit losses
    		        -7,000 -11,000 -39,000              
      change in property and equipment acquired but not yet paid
    		         246,000 267,000              
      benefit from doubtful accounts
    		            0 -27,000 -65,000 0 -124,000 0 514,000      
      proceeds from issuance of common stock upon follow-on public offering
    		            0   0 0        
      payment of common stock issuance costs upon follow-on public offering
    		            0   0 0        
      forgiveness of stock subscriptions receivable
    		                        
      change in fair value of warrants
    		                        
      proceeds from issuance of common stock upon initial public offering
    		                        
      payment of common stock issuance costs upon initial public offering
    		                        
      proceeds from issuance of preferred stock and noncontrolling interest
    		                       0 
      payment of preferred stock issuance costs
    		                       0 
      repurchase of common stock
    		                        
      common stock issuance on stock option exercises for promissory notes
    		                       0 
      warrants issued as debt issuance costs
    		                       493,000 
      proceeds from sale of short-term investments
    		                       7,200,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.